These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 26111222

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM, Tsai HC, Lee SS, Kunin C, Lin PC, Wann SR, Chen YS.
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [Abstract] [Full Text] [Related]

  • 3. Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection.
    Jundt F, Lempert T, Dörken B, Pezzutto A.
    Infection; 2004 Jun; 32(3):176-8. PubMed ID: 15188079
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
    Ohmura SI, Naniwa T, Tamechika SY, Miyamoto T, Shichi D, Kazawa N, Iwagaitsu S, Maeda S, Wada JI, Niimi A.
    J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with rheumatic diseases.
    Harada T, Kato R, Sueda Y, Funaki Y, Takata M, Okazaki R, Hasegawa Y, Yamasaki A.
    Mod Rheumatol; 2021 May; 31(3):629-635. PubMed ID: 32820678
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.
    Chen RY, Li DW, Wang JY, Zhuang SY, Wu HY, Wu JJ, Qu JW, Sun N, Zhong C, Zhu C, Zhang M, Yu YT, Yuan XD.
    Int J Infect Dis; 2022 Dec; 125():209-215. PubMed ID: 36243280
    [Abstract] [Full Text] [Related]

  • 13. Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary Pneumocystis jirovecii co-infection: A case report.
    le Noble JLML, Foudraine N, van der Elst KCM, Bouwman S.
    Int J Clin Pharmacol Ther; 2023 Nov; 61(11):525-530. PubMed ID: 37489071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
    Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H, Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Tomita M, Kihara M, Yokoyama W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Kohsaka H, Miyasaka N, Harigai M.
    Arthritis Res Ther; 2017 Jan 18; 19(1):7. PubMed ID: 28100282
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study.
    Kato H, Hagihara M, Asai N, Mikamo H, Iwamoto T.
    Int J Antimicrob Agents; 2024 May 18; 63(5):107151. PubMed ID: 38508538
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.